Clinical trials

Compound	NCT Number	Status	Phases	Study title	Conditions	URL
WP1066	NCT01904123	Recruiting	Phase 1	STAT3 Inhibitor WP1066 in Treating Patients With Recurrent Malignant Glioma or Progressive Metastatic Melanoma in the Brain	Metastatic Malignant Neoplasm in the Brain\|Metastatic Melanoma\|Recurrent Brain Neoplasm\|Recurrent Glioblastoma\|Recurrent Malignant Glioma	https://ClinicalTrials.gov/show/NCT01904123